title: Severe virus influenza A H1N1 related pneumonia and community-acquired pneumonia: differences in the evolution.
abstract: OBJECTIVE
  To analyze the clinical, laboratory and evolution data of patients with severe influenza A H1N1 pneumonia and compare the data with that of patients with severe community-acquired bacterial pneumonia.
  
  
  METHODS
  Cohort and retrospective study. All patients admitted to the intensive care unit between May 2009 and December 2010 with a diagnosis of severe pneumonia caused by the influenza A H1N1 virus were included in the study. Thirty patients with severe community-acquired pneumonia admitted within the same period were used as a control group. Severe community-acquired pneumonia was defined as the presence of at least one major severity criteria (ventilator or vasopressor use) or two minor criteria.
  
  
  RESULTS
  The data of 45 patients were evaluated. Of these patients, 15 were infected with H1N1. When compared to the group with community-acquired pneumonia, patients from the H1N1 group had significantly lower leukocyte counts on admission (6,728±4,070 versus 16,038±7,863; p<0.05) and lower C-reactive protein levels (Day 2: 15.1±8.1 versus 22.1±10.9 mg/dL; p<0.05). The PaO2/FiO2 ratio values were lower in the first week in patients with H1N1. Patients who did not survive the H1N1 severe pneumonia had significantly higher levels of C-reactive protein and higher serum creatinine levels compared with patients who survived. The mortality rate was significantly higher in the H1N1 group than in the control group (53% versus 20%; p=0.056, respectivelly).
  
  
  CONCLUSIONS
  Differences in the leukocyte count, C-reactive protein concentrations and oxygenation profiles may contribute to the diagnosis and prognosis of patients with severe influenza A H1N1 virus-related pneumonia and community-acquired pneumonia.
authors.affiliation: Faculdade de Medicina de São José do Rio Preto - FAMERP - São José do Rio Preto SP, Brazil.
authors.forename: Paula
authors.initials: P
authors.lastname: Nardocci
authors.forename: Caio Eduardo
authors.initials: CE
authors.lastname: Gullo
authors.forename: Suzana Margareth
authors.initials: SM
authors.lastname: Lobo
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002097:C-Reactive Protein / Q000378:metabolism; D015331:Cohort Studies; D017714:Community-Acquired Infections / Q000401:mortality / Q000503:physiopathology*; D005260:Female; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000302:isolation & purification; D007251:Influenza, Human / Q000401:mortality / Q000503:physiopathology*; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000378:metabolism; D018410:Pneumonia, Bacterial / Q000401:mortality / Q000503:physiopathology*; D011024:Pneumonia, Viral / Q000401:mortality / Q000503:physiopathology*; D011379:Prognosis; D011446:Prospective Studies; D012189:Retrospective Studies; D012720:Severity of Illness Index; D055815:Young Adult
chemical_list: D002097:C-Reactive Protein; D010100:Oxygen
references.citation: J Bras Pneumol. 2012 Jan-Feb;38(1):7-12
references.pmid: 22407035
references.citation: Clin Chem Lab Med. 2010;48(1):11-21
references.pmid: 20025556
references.citation: Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72
references.pmid: 17278083
references.citation: J Infect. 2010 Sep;61(3):205-11
references.pmid: 20600303
references.citation: Ann Saudi Med. 2010 Jan-Feb;30(1):11-4
references.pmid: 20103952
references.citation: Crit Care. 2009;13(5):R148
references.pmid: 19747383
references.citation: Rev Bras Ter Intensiva. 2009 Aug;21(3):231-6
references.pmid: 25303543
references.citation: Crit Care Med. 2008 Jan;36(1):166-71
references.pmid: 18007271
references.citation: JAMA. 2009 Nov 4;302(17):1896-902
references.pmid: 19887665
references.citation: Contrib Nephrol. 2010;165:310-314
references.pmid: 20427982
references.citation: Crit Care. 2012 Aug 15;16(4):R155
references.pmid: 22894879
references.citation: PLoS Curr. 2009 Dec 07;1:RRN1133
references.pmid: 20029670
references.citation: MMWR Morb Mortal Wkly Rep. 2003 Dec 12;52(49):1202-6
references.pmid: 14668711
references.citation: Biomed Pharmacother. 2013 Apr;67(3):218-20
references.pmid: 23466363
references.citation: JAMA. 2009 Nov 4;302(17):1880-7
references.pmid: 19822626
references.citation: Eur Respir J. 2008 Sep;32(3):726-32
references.pmid: 18508833
references.citation: N Engl J Med. 2010 May 6;362(18):1708-19
references.pmid: 20445182
references.citation: BMC Infect Dis. 2010 Oct 04;10:288
references.pmid: 20920320
references.citation: PLoS One. 2009 Dec 31;4(12):e8540
references.pmid: 20046873